Chamaeleo Pharma hires Han Van t Klooster as Vice President of Commercial Operations

He joins the Belgian company from Pharmion Europe

Belgian oncology company Chamaeleo Pharma says Han Van ‘t Klooster has joined the company as Vice President of Commercial Operations.

Van ‘t Klooster will be a member of Chamaeleo’s Management team and will be responsible for the market access and commercial launch of the company’s lead product Fosfestrol for the treatment of advanced prostate cancer.

Van ‘t Klooster has more than 20 years of business experience in the pharmaceutical industry. Prior to joining Chamaeleo, he was General Manager of Pharmion Europe (acquired by Celgene).

Prior to this, he was International Marketing Director Oncology at Chiron Corporation (acquired by Novartis). He started his career at AstraZeneca as a Product Manager.

You may also like

Packaging

Innovating primary packaging for parenteral drugs: challenges and future directions

The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class
Manufacturing

Servier opens new €86m biologics production facility in Loiret, France

The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies
Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Subscribe now